- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 495/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 495/10
Total number of patents in this class: 493
10-year publication summary
|
27
|
31
|
52
|
36
|
23
|
45
|
28
|
42
|
32
|
25
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 193 |
38 |
| Janssen Pharmaceutica N.V. | 3171 |
14 |
| Bayer Pharma AG | 1014 |
14 |
| Merck Patent GmbH | 5725 |
11 |
| Gilead Sciences, Inc. | 2220 |
10 |
| Union Therapeutics A/S | 58 |
10 |
| SFC Co., Ltd. | 335 |
9 |
| Bristol-myers Squibb Company | 4729 |
8 |
| Genentech, Inc. | 4099 |
8 |
| Amgen Inc. | 4425 |
8 |
| Novartis AG | 10263 |
7 |
| Hoffmann-La Roche Inc. | 3783 |
7 |
| Vertex Pharmaceuticals Incorporated | 1584 |
7 |
| F. Hoffmann-La Roche AG | 7836 |
6 |
| Takeda Pharmaceutical Company Limited | 2715 |
6 |
| Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | 344 |
6 |
| Convelo Therapeutics, Inc. | 19 |
6 |
| Merck Sharp & Dohme LLC | 3735 |
6 |
| Samsung Display Co., Ltd. | 38570 |
5 |
| Boehringer Ingelheim International GmbH | 4493 |
5 |
| Other owners | 302 |